JAK2 and osteosclerosis: It gives clues on the mechanisms on how JAK2 inhibition may modulate platelet counts, block marrow fibrosis and osteosclerosis and prevent mobilization of early neoplastic cells in extramedullary sites decreasing splenomegaly.